SectorPharmaceutical
Established Date07/02/2008
Listing Date22/05/2013
ExchangeNASDAQ Stock Exchange
Full-time Employees106
Fiscal Year Ends31/12
Security TypeCommon stock
Office address10285 Science Center Drive, San Diego, California 92121
Business
IntroductionArcturus Therapeutics Holdings Inc., incorporated and commenced operations in Israel on February 7, 2008, and re-incorporated in Delaware. The company is a messenger ribonucleic acid drug company focused on developing therapies for rare diseases of the liver and respiratory tract. Its platform technologies include a proprietary self-replicating mRNA and lipid nanoparticle delivery system, supporting a pipeline of drug candidates for diseases such as ornithine carbamyltransferase deficiency and cystic fibrosis, and a co-developed COVID - 19 vaccine.
